Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)
CNY 13.48
(-1.1%)
CNY 13.48
(-1.1%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 305.97 Million CNY | -21.61% |
| 2022 | 328.9 Million CNY | -10.52% |
| 2021 | 367.59 Million CNY | 11.36% |
| 2020 | 330.09 Million CNY | 10.56% |
| 2019 | 298.57 Million CNY | 155.68% |
| 2018 | 116.77 Million CNY | 44.15% |
| 2017 | 81.01 Million CNY | 10.53% |
| 2016 | 73.29 Million CNY | 89.43% |
| 2015 | 38.69 Million CNY | -10.59% |
| 2014 | 43.27 Million CNY | 13.35% |
| 2013 | 38.17 Million CNY | 5.61% |
| 2012 | 36.14 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -20.8 Million CNY | -190.62% |
| 2024 Q1 | 92.55 Thousand CNY | -99.9% |
| 2024 Q2 | 22.96 Million CNY | 24708.19% |
| 2023 Q1 | 53.66 Million CNY | -45.0% |
| 2023 FY | 257.83 Million CNY | -21.61% |
| 2023 Q2 | 61.33 Million CNY | 14.28% |
| 2023 Q4 | 89.8 Million CNY | 56.25% |
| 2023 Q3 | 57.47 Million CNY | -6.29% |
| 2022 Q1 | 80.33 Million CNY | -39.31% |
| 2022 Q4 | 97.58 Million CNY | 72.14% |
| 2022 Q3 | 56.68 Million CNY | -27.68% |
| 2022 Q2 | 78.38 Million CNY | -2.42% |
| 2022 FY | 328.9 Million CNY | -10.52% |
| 2021 FY | 367.59 Million CNY | 11.36% |
| 2021 Q3 | -128.49 Million CNY | -230.67% |
| 2021 Q4 | 132.35 Million CNY | 203.01% |
| 2021 Q1 | 77.54 Million CNY | -15.63% |
| 2021 Q2 | 98.33 Million CNY | 26.82% |
| 2020 Q3 | 91.9 Million CNY | -5.96% |
| 2020 FY | 330.09 Million CNY | 10.56% |
| 2020 Q4 | 91.9 Million CNY | 0.0% |
| 2020 Q2 | 97.72 Million CNY | 154.57% |
| 2020 Q1 | 38.38 Million CNY | -48.11% |
| 2019 Q3 | 73.98 Million CNY | 23.78% |
| 2019 Q2 | 59.77 Million CNY | -0.0% |
| 2019 Q4 | 73.98 Million CNY | 0.0% |
| 2019 Q1 | 59.77 Million CNY | 95.06% |
| 2019 FY | 298.57 Million CNY | 155.68% |
| 2018 Q2 | 26.23 Million CNY | -0.0% |
| 2018 FY | 116.77 Million CNY | 44.15% |
| 2018 Q4 | 30.64 Million CNY | 0.0% |
| 2018 Q3 | 30.64 Million CNY | 16.79% |
| 2018 Q1 | 26.23 Million CNY | 43.1% |
| 2017 Q3 | 18.33 Million CNY | -3.92% |
| 2017 Q2 | 19.08 Million CNY | 0.0% |
| 2017 FY | 81.01 Million CNY | 10.53% |
| 2017 Q4 | 18.33 Million CNY | 0.0% |
| 2017 Q1 | 19.08 Million CNY | 43.85% |
| 2016 Q2 | 19.22 Million CNY | 0.0% |
| 2016 FY | 73.29 Million CNY | 89.43% |
| 2016 Q3 | 13.26 Million CNY | -31.0% |
| 2016 Q1 | 19.22 Million CNY | 257.29% |
| 2016 Q4 | 13.26 Million CNY | 0.0% |
| 2015 Q4 | 5.38 Million CNY | 0.0% |
| 2015 Q2 | 13.79 Million CNY | 0.0% |
| 2015 Q3 | 5.38 Million CNY | -61.0% |
| 2015 Q1 | 13.79 Million CNY | -19.69% |
| 2015 FY | 38.69 Million CNY | -10.59% |
| 2014 Q4 | 17.18 Million CNY | 0.0% |
| 2014 Q2 | 11.13 Million CNY | 0.0% |
| 2014 Q1 | 11.13 Million CNY | -33.86% |
| 2014 FY | 43.27 Million CNY | 13.35% |
| 2013 Q4 | 16.83 Million CNY | 0.0% |
| 2013 FY | 38.17 Million CNY | 5.61% |
| 2012 FY | 36.14 Million CNY | 0.0% |